Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Edad cerebral y arquitectura del sueño en meditadores (BRANCH)

25 de septiembre de 2026 actualizado por: Balachundhar Subramaniam, Beth Israel Deaconess Medical Center

This is a single-center, cross-sectional study that will recruit approximately fifty seven (57) meditators and fifty one (51) controls. Individuals that have learned at least the Shambhavi Mahamudra Kriya practice and live in Massachusetts will be mailed a DREEM EEG device, and a sleepimage ring. Participants will be asked to wear the two devices while sleeping for three consecutive weekday nights (Sunday night to Thursday night) and two weekend nights (Friday and Saturday nights). While meditating during the day, participants will only wear the DREEM EEG headband. Participants will also undergo neurocognitive tests from the NIH toolbox during one virtual visit via video call. Meditators who join the study will be asked to invite a control subject to the study, matched for age and comorbidities.

Descripción general del estudio

Estado

Activo, no reclutando

Condiciones

Descripción detallada

Approximately one hundred and eight (108) individuals will undergo three consecutive weekday nights and two weekend nights of EEG and plethysmography recording using the DREEM headband and SleepImage rings, after answering a demographic questionnaire. Out of these 108 participants, the study will aim for 57 meditators and 51 matched controls. Only meditating participants will be asked to perform the most advanced form of meditation among the following three, which are listed from least advanced to most advanced: Shambhavi Mahamudra Kriya, Shoonya Meditation, Samyama Meditation (Breath watching). Participants will be instructed to wear the DREEM EEG headband during their practice of this meditation during each of the five days.

All participants will also be asked to undergo cognitive assessments from the NIH toolbox during a video call. The assessments from the NIH toolbox will last approximately forty-five minutes to one hour.

EEG: The participants will be mailed the DREEM devices and asked to wear them for three consecutive weekday nights and two weekend nights while sleeping. During the day, for each of these five nights, meditating participants will also be asked to wear the device while they sit still with their eyes closed, without trying to meditate, for 10 minutes. This will function as the baseline waking EEG measurement. Immediately following this, participants will be asked to perform their meditation while wearing the DREEM device for a maximum of 30 minutes.

NIH Toolbox:

This study will use select tests from the NIH Toolbox Cognition Battery and from the NIH Toolbox Emotion Battery. All of the tests together will take approximately 45 minutes to 1 hour to complete.

The selected tests from the batteries are the following:

Cognition Battery

  1. Picture vocabulary test
  2. List sorting working memory test
  3. Picture Sequence Memory test
  4. Oral reading recognition test

Emotion Battery:

  1. Positive Affect CAT
  2. General Life Satisfaction CAT
  3. Emotional Support FF
  4. Instrumental Support FF
  5. Friendship FF
  6. Loneliness FF
  7. Perceived Stress FF

Retrospective Survey:

Participants will also be asked to complete a retrospective questionnaire assessing meditation practice characteristics and alarm use during their original study participation.

Tipo de estudio

De observación

Inscripción (Actual)

108

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Beth Israel Deaconess Medical Centre

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Subjects will not be recruited based on race, ethnicity, or gender. However, it is not clear whether the final study sample will contain a representative spread of the racial and gender makeup.

Descripción

Inclusion Criteria (Meditators):

  1. Previous experience with learning Shambhavi Mahamudra Kriya
  2. Age 18 years or older.
  3. Lives in the United States barring California

Inclusion Criteria (Controls):

  1. Age 18 years or older
  2. Lives in the United States barring California

Exclusion Criteria (both groups):

  1. Non-English Speaking
  2. Night Shift workers

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Meditation

This is the group that will have learned at least Shamhbavi Mahamudra Kriya before they are enrolled in the study.

The DREEM EEG device will be used to measure brain age.

The SleepImage ring uses plethysmography to analyze sleep architecture and cardiopulmonary coupling.

Control

This is the group that will not have learned Shambhavi Mahamudra Kriya before they are enrolled in the study. They will be invited to the study by the Meditation group.

The DREEM EEG device will be used to measure brain age.

The SleepImage ring uses plethysmography to analyze sleep architecture and cardiopulmonary coupling.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sleep Architecture - DREEM EEG
Periodo de tiempo: Measured across 5 nights (3 weekday and 2 weekend nights) during the data collection period.

Sleep architecture will be assessed using overnight DREEM EEG recordings. Measures will include including total sleep time, sleep efficiency, and sleep stage duration. Measures will be aggregated across available high-quality recordings for each participant.

Measured across 5 nights (3 weekday and 2 weekend nights) during the data collection period.
Brain Age
Periodo de tiempo: Measured for 3 weekday and 2 weekend nights during the data collection period

Brain Age will be calculated using an algorithm from the sleeping EEG. A Brain Age index score will be created for each participant based on an aggregate of the five days of sleeping EEG data. The Brain Age Index is the brain age calculated from the algorithm subtracted by the chronological age of the participant.

Measured for 3 weekday and 2 weekend nights during the data collection period
Sleep Measures - SleepImage Ring
Periodo de tiempo: Measured across 5 nights (3 weekday and 2 weekend nights).

Sleep and cardiopulmonary measures will be assessed using the SleepImage Ring.

Measured across 5 nights (3 weekday and 2 weekend nights).
Cognitive Function
Periodo de tiempo: Assessed once during the study period.

Cognitive function will be assessed using the NIH Toolbox Cognition Battery: Picture Vocabulary, List Sorting Working Memory, Picture Sequence Memory, and Oral Reading Recognition Tests.

Assessed once during the study period.
Emotion
Periodo de tiempo: Assessed once during the study period.

Emotional and psychosocial functioning will be assessed using the NIH Toolbox Emotion Battery: Positive Affect, General Life Satisfaction, Emotional Support, Instrumental Support, Friendship, Loneliness, and Perceived Stress measures.

Assessed once during the study period.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Retrospective Meditation and Sleep Information
Periodo de tiempo: Assessed once retrospectively following study participation.

Meditators will report meditation type, frequency, and consistency; meditators and controls will report regular alarm use during the study period.

Assessed once retrospectively following study participation.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de noviembre de 2022

Finalización primaria (Actual)

4 de julio de 2025

Finalización del estudio (Estimado)

31 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

22 de agosto de 2022

Primero enviado que cumplió con los criterios de control de calidad

22 de agosto de 2022

Publicado por primera vez (Actual)

24 de agosto de 2022

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

30 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

25 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2022P000597

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir